BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

  May 7, 2026

   · 

  10 min read
• Press Releases

  Microbix Schedules Release of Results for Q2 Fiscal 2026

  May 7, 2026

   · 

  4 min read
• Press Releases

  Wegovy® access expanded for Medicare beneficiaries living with obesity through the Medicare GLP-1 Bridge starting July 1, 2026

  May 7, 2026

   · 

  11 min read
• Press Releases

  TORL BioTherapeutics Appoints Aran Maree, M.D., as Chief Executive Officer and Evolves Leadership for Next Phase of Growth

  May 7, 2026

   · 

  5 min read
• Press Releases

  Viatris Reports First-Quarter 2026 Financial Results

  May 7, 2026

   · 

  31 min read
• Press Releases

  Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

  May 7, 2026

   · 

  6 min read
• Press Releases

  Ukko Announces First Participant Dosed in Phase 1/2a Clinical Study Evaluating UKK-0018 for Peanut Allergy Treatment

  May 7, 2026

   · 

  3 min read
• Press Releases

  Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

  May 7, 2026

   · 

  19 min read
• Press Releases

  Charles River Laboratories Announces First-Quarter 2026 Results

  May 7, 2026

   · 

  20 min read
• Press Releases

  Parabilis Medicines Appoints Biopharmaceutical Finance Leader Alan M. Sebulsky to Board of Directors

  May 7, 2026

   · 

  2 min read